Last updated 2026-07-23
Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
4
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
ApoRx is a drug discovery company that focuses on the discovery, design, characterization, and development of small proteolysis targeting molecules (PTMs). These molecules are designed to degrade and destroy unwanted proteins implicated in cancer and other diseases by harnessing the intracellular Ubiquitin-Proteasome machinery. Their core technology is the 'Aperion library,' a proprietary focus library of RING E3 ligase binders. ApoRx is a subsidiary of Agbiopro Protein Degradation Hub, a management and consulting firm.
Headcount over time
From 6 (2021-01) to 7 (2026-07) · +1 (+17%) · 7 points · source: Finder history + radar grounding
Q&A
- What is ApoRx Biopharmaceuticals' primary focus?
- ApoRx Biopharmaceuticals is a drug-discovery company focused on the discovery, design, characterization, and development of small proteolysis-targeting molecules against disease-causing proteins in cancer and other indications.
- What is the core technology of ApoRx Biopharmaceuticals?
- The core of ApoRx Biopharmaceuticals' technology is the Aperion library, a proprietary focus library of RING E3 ligase binders designed to harness the intracellular ubiquitin-proteasome machinery for targeted protein degradation.
- When was ApoRx Biopharmaceuticals founded?
- ApoRx Biopharmaceuticals was founded in January 2021.
- How many employees does ApoRx Biopharmaceuticals have?
- ApoRx Biopharmaceuticals has 4 employees, falling within the 1-10 employee bucket.
- What is ApoRx Biopharmaceuticals' current funding stage?
- ApoRx Biopharmaceuticals is currently in the Pre-Funding stage.
- Who are the founders of ApoRx Biopharmaceuticals?
- The founders of ApoRx Biopharmaceuticals include Avishai Levy (Co-founder & CEO), Omri Erez (Founder), Philippe Nakache (Co-founder), and Orna Harel (Co-founder).
- What sector does ApoRx Biopharmaceuticals primarily operate in?
- ApoRx Biopharmaceuticals' primary sector is Health Tech & Life Sciences.
- What is the relationship between ApoRx Biopharmaceuticals and Agbiopro Protein Degradation Hub?
- ApoRx Biopharmaceuticals is a subsidiary of Agbiopro Protein Degradation Hub, which is a management and consulting firm.
Team · 4
Avishai Levy
Founder · Co-founder & CEO
Omri Erez
Founder · Founder
Orna Harel
Founder · Co-founder
Philippe Nakache
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
oncologypharmaceuticalsimmunotherapypharma-companiesbiotechnologydrug-discoverydrug-designbiopharmaceuticalcancer-therapycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | aporxbio.com/ |
|---|---|
| linkedin.com/company/70961472 |
Identifiers & details
| Legal name | ApoRx Biopharmaceuticals Ltd. |
|---|---|
| Founded | 2021-1 |
| Employees (exact) | 4 |
Radar intelligence
Web history (Wayback)
| Domain | aporxbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516313756 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-01-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | אצ~ל 19 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-16 | דו~ח שנתי-עדכון תחום עיסוק |